Medical Device Marketing Agency SLAs: What to Include in Your Contract

Why Service Level Agreements Matter in Medical Device Marketing

A service level agreement, or SLA, defines the standards, responsibilities, and expectations that govern the relationship between a medical device company and its marketing agency. While many agency engagements operate on informal understandings and general contracts, formalizing expectations through an SLA protects both parties and sets the foundation for a productive, accountable partnership.

Medical device marketing is uniquely demanding. Regulatory compliance requirements, clinical accuracy standards, complex approval workflows, and time-sensitive trade show deadlines make it essential to have clear, documented agreements about how work will be managed, reviewed, and delivered. A well-crafted SLA prevents misunderstandings, provides recourse when standards are not met, and creates a framework for continuous improvement.

At Buzzbox Media, we work with medical device companies that understand the value of structured partnerships. This guide covers the key provisions your SLA should include, common pitfalls to avoid, and best practices for creating an agreement that serves both your agency and your commercial objectives.

Core Components of a Medical Device Marketing Agency SLA

Scope of Services and Deliverables

The foundation of any SLA is a clear definition of the services included in the engagement. For medical device marketing agencies, this typically encompasses a defined set of ongoing services and a process for handling ad hoc project requests. The SLA should specify exactly which services are included in the base retainer or engagement fee and which constitute additional scope requiring separate estimates and approval.

For retainer engagements, the scope section might define monthly deliverables such as a certain number of blog posts, email campaigns, social media posts, or design projects. For project-based engagements, the scope should detail specific deliverables with clear specifications, including format, dimensions, file types, and intended use.

Importantly, the scope section should address how scope changes are handled. Medical device marketing needs evolve throughout the year, and the SLA should include a clear process for requesting, estimating, and approving out-of-scope work. This prevents scope creep from eroding the agency's capacity for committed deliverables while giving the client flexibility to address emerging needs.

Response Time Standards

Response time provisions define how quickly the agency will acknowledge and begin working on requests. These standards should differentiate between request types, as not all requests carry the same urgency. A typical response time framework for medical device marketing might include the following tiers.

Standard requests, such as routine content creation, design updates, or monthly reporting, might carry a 24-hour acknowledgment commitment and a defined turnaround time based on deliverable complexity. Urgent requests, such as conference deadline materials or time-sensitive regulatory responses, might require acknowledgment within four hours and prioritized production scheduling. Emergency requests, such as product recalls or FDA correspondence requiring immediate marketing action, might require immediate acknowledgment and same-day initial response.

These response time standards should be realistic and mutually agreed upon. Setting unrealistically fast response times creates frustration on both sides when they inevitably cannot be met. At Buzzbox Media, we establish response time expectations during the onboarding process and adjust them based on actual workflow patterns as the relationship matures.

Turnaround Times for Common Deliverables

Beyond initial response times, the SLA should specify expected turnaround times for common deliverable types. These commitments help both parties plan project timelines and manage stakeholder expectations. Typical turnaround time provisions for medical device marketing deliverables include the following guidelines.

Simple deliverables like social media graphics, minor copy updates, or email template modifications might carry a two to three business day turnaround. Standard deliverables like product sell sheets, blog posts, or email campaigns might require five to seven business days. Complex deliverables like product brochures, clinical white papers, or website pages might need ten to fifteen business days. Major projects like product launch campaigns, trade show programs, or catalog designs might require four to eight weeks depending on scope and complexity.

These timelines should account for the client's review and approval process. A common source of friction in agency relationships is when turnaround time expectations do not include the time needed for internal client review, regulatory approval, and feedback incorporation. The SLA should clarify that turnaround times begin when the agency receives all necessary inputs, including approved copy, images, and clinical data, and that client review periods are separate from agency production time.

Quality Standards and Compliance Provisions

Regulatory Compliance Requirements

For medical device marketing, regulatory compliance provisions are among the most important elements of the SLA. The agreement should clearly define each party's responsibilities regarding compliance with FDA promotional guidelines, FTC requirements, and any international regulations applicable to the client's markets.

Typically, the SLA should specify that the agency will produce materials that comply with applicable regulations and the client's internal compliance standards. It should also clarify that the client retains ultimate responsibility for regulatory approval of all marketing materials and that the agency's compliance review does not substitute for the client's regulatory affairs review. For comprehensive guidance on these requirements, refer to our medical device marketing guide.

The SLA should outline the agency's compliance review process, including who reviews materials for regulatory compliance, what guidelines they reference, and how compliance concerns are documented and communicated. This transparency ensures both parties understand the level of regulatory oversight the agency provides and where the client's internal review process picks up.

Clinical Accuracy Standards

Medical device marketing content must be clinically accurate, and the SLA should address standards for clinical content quality. This includes provisions for how clinical claims are sourced and substantiated, how clinical data is presented and referenced, and what qualifications the agency's content writers have for producing clinical material.

The SLA might specify that all clinical claims must be traceable to published clinical evidence, that mechanism of action descriptions must be reviewed against the device's technical documentation, and that clinical content will be reviewed by a team member with relevant scientific or clinical background. These provisions protect both parties by establishing clear standards for the accuracy and credibility of clinical marketing content.

Brand Consistency and Design Standards

The SLA should reference the client's brand guidelines and establish the agency's commitment to maintaining brand consistency across all deliverables. This includes visual standards such as logo usage, color palettes, typography, and imagery style, as well as messaging standards like tone of voice, terminology preferences, and approved claims language.

If the client does not have comprehensive brand guidelines, the SLA might include a provision for the agency to develop or document brand standards as part of the initial engagement, with client approval. Establishing clear brand standards at the outset prevents inconsistencies that can undermine the professional image your medical device marketing program needs to maintain.

Communication and Reporting Provisions

Regular Communication Cadences

Effective agency relationships require structured communication, and the SLA should define the cadences and formats for regular interactions. Common communication provisions include weekly status calls or updates that review work in progress, upcoming deadlines, and any blockers or issues requiring attention. Monthly performance reviews should cover metrics reporting, deliverable summaries, and strategic discussions about upcoming priorities.

Quarterly business reviews provide deeper strategic assessments of the marketing program, competitive landscape changes, and recommendations for the next quarter. The SLA should specify who from each organization participates in these meetings, what materials are prepared in advance, and how action items are documented and tracked.

Performance Reporting Requirements

The SLA should define what metrics the agency will track and report, how frequently reports are delivered, and what format they take. For medical device marketing programs, relevant metrics might include website traffic and engagement data, content performance metrics, lead generation numbers, SEO performance indicators like keyword rankings and organic traffic, email marketing metrics, social media engagement, and trade show ROI calculations.

Reports should provide not just data but analysis and recommendations. A monthly report that simply lists metrics without context or strategic interpretation provides little value. The SLA should specify that reporting includes performance analysis, trend identification, and recommended optimizations based on the data.

Feedback and Revision Processes

The SLA should define clear processes for providing feedback on deliverables and managing revisions. This includes specifying how many rounds of revisions are included in the base scope, what constitutes a revision versus a new direction that triggers additional scope, and how feedback should be consolidated and communicated to minimize confusion.

A common provision is to include two rounds of revisions for standard deliverables, with additional rounds billed at hourly rates. The SLA should also address the feedback timeline, specifying how quickly the client will provide feedback after receiving deliverables. Delayed client feedback is one of the most common causes of project delays, and having a defined feedback window helps both parties maintain production schedules.

Intellectual Property and Confidentiality

Work Product Ownership

The SLA should clearly state that the client owns all work product created by the agency during the engagement. This includes design files, copy, photography, illustrations, website code, and any other creative assets produced under the agreement. The agency should provide source files in editable formats, not just final exports, so the client can modify materials if needed.

Some agencies retain ownership of work product until final payment is received, which is a reasonable provision that protects the agency's interests. However, the transfer of ownership upon payment should be automatic and unconditional. Avoid agreements where the agency retains perpetual rights to use your marketing materials in their portfolio or for other purposes without your explicit consent.

Confidentiality and Non-Disclosure

Medical device companies share sensitive information with their agencies, including pre-launch product details, clinical trial data, competitive intelligence, financial information, and proprietary technology specifications. The SLA should include robust confidentiality provisions that protect this information during and after the engagement.

Confidentiality provisions should specify what constitutes confidential information, how it must be stored and protected, who within the agency may access it, and how long confidentiality obligations survive after the engagement ends. For medical device companies with pending patents or ongoing clinical trials, these provisions are particularly critical.

Non-Compete and Conflict of Interest Provisions

Consider including provisions that address competitive conflicts. The SLA might prohibit the agency from simultaneously working with direct competitors, require the agency to disclose potential conflicts as they arise, and establish information barriers if the agency does serve clients in adjacent market segments.

These provisions protect your competitive information and ensure the agency's strategic advice is not compromised by conflicting client relationships. At Buzzbox Media, we maintain strict policies about competitive accounts and proactively disclose any potential conflicts to our clients before they become issues.

Termination and Transition Provisions

Termination Clauses

The SLA should include clear termination provisions that protect both parties. Common elements include a notice period requirement, typically 30 to 60 days for retainer engagements, that gives both parties time to plan for the transition. Termination for cause provisions should allow either party to end the agreement immediately if the other party materially breaches the SLA, fails to cure a breach within a specified timeframe, or experiences insolvency or other disqualifying events.

The agreement should also address what happens to work in progress at the time of termination. Typically, the agency completes any work that has already been started and invoiced, and the client pays for all completed and in-progress work up to the termination date.

Transition and Handoff Requirements

A thorough SLA includes transition provisions that ensure a smooth handoff if the engagement ends. The agency should be required to provide all source files, brand assets, login credentials, and documentation to the client or their successor agency within a specified timeframe after termination. The SLA should also address knowledge transfer, including documenting ongoing campaigns, content calendars, and strategic plans so the client can continue their marketing program without disruption.

Transition provisions are often overlooked during the excitement of starting a new agency relationship, but they are critical for protecting your marketing investment. Without clear transition requirements, ending an agency relationship can result in lost files, disrupted campaigns, and months of recovery time as a new partner rebuilds institutional knowledge.

Performance Benchmarks and Accountability

Defining Success Metrics

The SLA should include specific performance benchmarks that define what success looks like for the engagement. These benchmarks should be measurable, realistic, and aligned with the client's commercial objectives. Examples include maintaining a minimum client satisfaction score based on quarterly surveys, achieving specific deliverable quality ratings, meeting turnaround time commitments at least 90 percent of the time, and delivering monthly reports on or before the agreed date.

Performance benchmarks give both parties objective criteria for evaluating the health of the relationship and identifying areas for improvement. Without defined benchmarks, performance discussions become subjective and potentially contentious.

Escalation Procedures

The SLA should define clear escalation procedures for when issues arise that cannot be resolved through normal communication channels. This typically includes a tiered escalation path starting with the day-to-day account team, escalating to senior management if needed, and ultimately involving executive leadership if resolution cannot be reached at lower levels.

Having defined escalation procedures prevents small issues from festering into relationship-ending problems. Both parties should know exactly how to raise concerns, who to contact at each level, and what resolution timeframes to expect. This structure provides a safety net that protects the partnership when challenges inevitably arise.

Financial and Payment Provisions

Payment Terms and Invoicing

The SLA should clearly define payment terms including invoice frequency, payment due dates, accepted payment methods, and any applicable late payment penalties. For retainer engagements, monthly invoicing with net-30 payment terms is standard in the medical device marketing industry. Project-based work may require milestone payments, with a percentage due at project kickoff, at midpoint, and upon final delivery.

Address how expenses are handled within the SLA. Common expense categories in medical device marketing include stock photography licenses, printing and production costs, media placements, trade show booth fabrication, software subscriptions, and travel for on-site meetings or trade show support. The SLA should specify which expenses are included in the retainer, which are passed through at cost, and which require pre-approval above a certain threshold.

Rate Changes and Annual Adjustments

Include provisions for how and when rates may change. Most agencies review pricing annually, and the SLA should specify the notice period required before a rate increase takes effect, typically 60 to 90 days. This gives the client time to evaluate the increase, adjust budgets if needed, or explore alternatives. Some SLAs cap annual rate increases at a specific percentage, such as 3 to 5 percent, to provide cost predictability for multi-year engagements.

Technology and Tool Access

Platform and Tool Ownership

Modern medical device marketing relies on numerous technology platforms including marketing automation systems, CRM integrations, analytics tools, social media management platforms, and project management software. The SLA should clarify which tools the agency will use, who pays for the subscriptions, and who retains access and ownership of data if the engagement ends.

As a general principle, the client should own all accounts, data, and credentials associated with their marketing program. If the agency sets up marketing automation, analytics, or advertising accounts on the client's behalf, those accounts should be in the client's name with the agency having delegated access. This ensures the client retains full control and data access regardless of the agency relationship status.

Data Security and Privacy

Medical device marketing may involve handling protected health information, clinical trial data, patient testimonials, or other sensitive data subject to HIPAA or international privacy regulations. The SLA should include data security provisions that specify how sensitive data is stored, transmitted, and protected. If the agency will have access to any data subject to HIPAA, a Business Associate Agreement should be executed alongside the SLA.

Even for non-HIPAA data, the SLA should address the agency's data security practices, including how they protect client proprietary information, what cybersecurity measures they maintain, and how data breaches would be reported and handled. These provisions are increasingly important as marketing technology becomes more data-intensive and cyber threats become more sophisticated.

Dispute Resolution

Handling Disagreements Constructively

Despite best intentions, disagreements between clients and agencies are inevitable. The SLA should include a dispute resolution provision that defines how conflicts are escalated and resolved before they damage the relationship or require legal intervention. A typical dispute resolution framework starts with good-faith negotiation between the parties, followed by mediation if direct negotiation fails, and arbitration or litigation as a last resort.

Specifying the governing jurisdiction and applicable law in the SLA prevents additional conflict if a dispute does reach legal proceedings. Many agencies and clients prefer to include mandatory mediation provisions before either party can pursue arbitration or litigation, as mediation is typically faster, less expensive, and more likely to preserve the business relationship.

Best Practices for SLA Development

Collaborate on the SLA

The best SLAs are developed collaboratively rather than imposed by one party on the other. Both the client and the agency should contribute to defining the standards, processes, and expectations that will govern their relationship. This collaborative approach ensures the SLA is realistic, balanced, and reflects the actual working dynamic between the organizations.

Review and Update Annually

An SLA should be a living document that evolves with the relationship. Review the SLA annually and update it to reflect changes in scope, processes, team structures, or business objectives. What works at the start of an engagement may need adjustment as both parties learn and the marketing program matures.

Start with Templates, Then Customize

While standard agency contract templates provide a useful starting point, medical device marketing SLAs require industry-specific customization. Generic marketing agency contracts rarely address regulatory compliance, clinical accuracy standards, or the unique approval workflows that medical device companies require. Start with a standard template but add provisions for FDA compliance, clinical content review, and the specialized turnaround requirements that come with trade show deadlines and product launch timelines.

Include Both Parties' Obligations

An effective SLA defines responsibilities for both the agency and the client. The agency commits to turnaround times, quality standards, and communication cadences. The client commits to providing timely feedback, supplying necessary inputs and approvals, and maintaining agreed-upon review cycles. When both parties have defined obligations, the relationship operates more smoothly and accountability is shared rather than one-sided.

Keep It Practical

Avoid overly complex SLAs that attempt to regulate every possible scenario. Focus on the provisions that have the most impact on day-to-day operations and partnership health. A practical, readable SLA that both parties actually reference and use regularly is far more valuable than a lengthy, overly detailed legal document that sits in a drawer collecting dust.

At Buzzbox Media in Nashville, we develop SLAs collaboratively with our medical device clients, ensuring that each agreement reflects the specific needs, workflows, and expectations of the partnership. Our goal is to create transparent, accountable relationships where both parties understand their commitments and can focus on producing marketing that drives commercial success for the devices we represent.